Address : 5937 Darwin Court, Carlsbad, California 92008, United States
Phone Number : +1-760-991-4466
Industries : Nanotechnology
Website : iridia.com
Company Description
Iridia™ Inc. strategically combines proprietary enzymology and semiconductor technology to revolutionize long-term data storage. By leveraging DNA, nature's perfected data storage system, the company has developed a durable, decodable, and ultra-high-density semiconductor chip solution for data storage, that significantly reduces the infrastructure requirements and environmental impact compared to current approaches. Iridia's solution is the world's first affordable, integrated data storage solution that can write, store, and read data on a single chip. Using proprietary nano memory cell technology and biochemistries, the company can manipulate single molecules of DNA to write information and read it back using the same device for a fraction of the cost of competing technologies. For more information, please visit www.iridia.com.
Specialities
- Nanotechnology
- Molecular Biology
- Nanotechnology Research
- Biochemistry
- Dna
Financial
Employees Total : 31
Revenue (Yearly) : 3M
Total Funding : 41.5M
Latest Funding : 6M
Miscellaneous
Founded in : 2016
Linkedin : iridia
Email Providers : Outlook
Hosting : 1&1 Hosting
CSS and JavaScript Libraries : Bootstrap Framework
Tag Management : Google Tag Manager
Tech : Mobile Friendly
CMS : WordPress.org
Last Updated : 2023-12-19
Employees
- Buck Watia ( Vice President, Head of Product and Corporate Development )
- Justin Briggs ( Board Member )
You Might Be Interested With:
 | IVIVA Medical Inc Woburn, Massachusetts, United States Research |
 | Antiverse Cardiff, Wales, United Kingdom Research |
 | Deep Science Ventures London, England, United Kingdom Venture Capital & Private Equity |
 | Accele Biopharma, Inc. Oklahoma City, Oklahoma, United States Pharmaceuticals |
 | Chorus Labs Oklahoma City, Oklahoma, United States Information Technology & Services |
 | Rebel One - RBL1 New York, United States Venture Capital & Private Equity |